Stockreport

Edesa Biotech Pushes Forward To Phase 2b Study For Lead Clinical Product [Seeking Alpha]

Edesa Biotech, Inc. - Common Shares  (EDSA) 
PDF Edesa Biotech Pushes Forward To Phase 2b Study For Lead Clinical Product Summary Edesa Biotech received go ahead from FDA to initiate its phase 2b study using EB01 to tr [Read more]